Stockscreener 앱 받기
9.76
0.41%
0.04
전일 마감가:
$9.72
열려 있는:
$9.66
하루 거래량:
1.22M
Relative Volume:
1.04
시가총액:
$737.40M
수익:
$11.40B
순이익/손실:
$-95.73M
주가수익비율:
-3.9837
EPS:
-2.45
순현금흐름:
$-64.37M
1주 성능:
+9.91%
1개월 성능:
+42.69%
6개월 성능:
+39.63%
1년 성능:
+3.61%
1일 변동 폭
$9.37
$9.8204
1주일 범위
$8.96
$10.24
52주 변동 폭
$4.70
$10.44
Mind Medicine Inc Stock (MNMD) Company Profile
명칭
Mind Medicine Inc
전화
212-220-6633
주소
ONE WORLD TRADE CENTER, NEW YORK
MNMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
9.76 | 734.38M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-28 | 개시 | Evercore ISI | Outperform |
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-10-14 | 재개 | Leerink Partners | Outperform |
| 2024-07-24 | 개시 | ROTH MKM | Buy |
| 2024-05-29 | 개시 | Robert W. Baird | Outperform |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | Canaccord Genuity | Buy |
| 2022-12-09 | 재개 | ROTH Capital | Buy |
| 2022-11-16 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-26 | 개시 | Oppenheimer | Outperform |
| 2022-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-04 | 개시 | ROTH Capital | Buy |
| 2021-06-28 | 개시 | Maxim Group | Buy |
모두보기
Mind Medicine Inc 주식(MNMD)의 최신 뉴스
Is Mind Medicine (MindMed) Inc. a good long term investmentTriple-digit returns - PrintWeekIndia
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD) - Seeking Alpha
MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025 - Business Wire
All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy - MSN
What analysts say about Mind Medicine (MindMed) Inc. stockExplosive capital appreciation - jammulinksnews.com
Mind Medicine (MindMed) Inc. Stock Analysis and ForecastExplosive capital appreciation - jammulinksnews.com
Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Nasdaq
What risks could impact Mind Medicine (MindMed) Inc. stock performanceFree Stock Market Beginners Guide - beatles.ru
(MNMD) Trading Signals - news.stocktradersdaily.com
What drives Mind Medicine (MindMed) Inc. stock priceLightning-fast capital gains - jammulinksnews.com
Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money
Mind Medicine stock rises as lawmakers discuss psychedelic therapy for veterans - Investing.com Canada
MindMed Announces New Employee Inducement Grants - Business Wire
Evercore ISI Sticks to Its Buy Rating for Mind Medicine (MNMD) - The Globe and Mail
Mind Medicine Inc.(NasdaqGS: MNMD) added to Russell 3000E Value Index - MarketScreener
Mind Medicine Executives Sell Shares to Cover Tax Obligations - TradingView
Psychedelic medicine stocks fall following Compass depression asset data (ATAI:NASDAQ) - Seeking Alpha
(MNMD) Trading Report - news.stocktradersdaily.com
Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com South Africa
Mind Medicine at H.C. Wainwright: Strategic Advances in Neuropsychiatry By Investing.com - Investing.com Canada
Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com
Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - MarketScreener
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - The Manila Times
Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne - Nasdaq
Groundbreaking Partnership: Incannex and Mind Medicine Launch Australia's Largest Psychedelic Therapy Center - Stock Titan
Mind Medicine Shareholders Approve Key Proposals at Annual Meeting - TipRanks
Analysts Offer Predictions for MNMD FY2026 Earnings - Defense World
MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Two Sigma Advisers LP Buys 5,400 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Ameriprise Financial Inc. Takes Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
(MNMD) Investment Report - news.stocktradersdaily.com
Millennium Management LLC Increases Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances - Investing.com Australia
Mind Medicine Inc (MNMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mind Medicine Inc 주식 (MNMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Karlin Daniel | Chief Medical Officer |
Jun 25 '25 |
Sale |
6.80 |
7,848 |
53,366 |
438,329 |
| Barrow Robert | Chief Executive Officer |
Jun 25 '25 |
Sale |
6.80 |
26,491 |
180,139 |
830,065 |
0.97%
0.22%
자본화:
|
볼륨(24시간):